ZINECARD Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Zinecard, and what generic alternatives are available?
Zinecard is a drug marketed by Pfizer and is included in one NDA.
The generic ingredient in ZINECARD is dexrazoxane hydrochloride. There are six drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the dexrazoxane hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Zinecard
A generic version of ZINECARD was approved as dexrazoxane hydrochloride by HIKMA on September 28th, 2004.
Summary for ZINECARD
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 100 |
Clinical Trials: | 27 |
Patent Applications: | 3,725 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for ZINECARD |
What excipients (inactive ingredients) are in ZINECARD? | ZINECARD excipients list |
DailyMed Link: | ZINECARD at DailyMed |
Recent Clinical Trials for ZINECARD
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Andrew E. Place | Phase 1 |
Children's Cancer Research Fund | Phase 1 |
University of Colorado, Denver | Phase 1 |
Anatomical Therapeutic Chemical (ATC) Classes for ZINECARD
US Patents and Regulatory Information for ZINECARD
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pfizer | ZINECARD | dexrazoxane hydrochloride | INJECTABLE;INJECTION | 020212-001 | May 26, 1995 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Pfizer | ZINECARD | dexrazoxane hydrochloride | INJECTABLE;INJECTION | 020212-002 | May 26, 1995 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for ZINECARD
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Pfizer | ZINECARD | dexrazoxane hydrochloride | INJECTABLE;INJECTION | 020212-001 | May 26, 1995 | ⤷ Try a Trial | ⤷ Try a Trial |
Pfizer | ZINECARD | dexrazoxane hydrochloride | INJECTABLE;INJECTION | 020212-002 | May 26, 1995 | ⤷ Try a Trial | ⤷ Try a Trial |
Pfizer | ZINECARD | dexrazoxane hydrochloride | INJECTABLE;INJECTION | 020212-001 | May 26, 1995 | ⤷ Try a Trial | ⤷ Try a Trial |
Pfizer | ZINECARD | dexrazoxane hydrochloride | INJECTABLE;INJECTION | 020212-002 | May 26, 1995 | ⤷ Try a Trial | ⤷ Try a Trial |
Pfizer | ZINECARD | dexrazoxane hydrochloride | INJECTABLE;INJECTION | 020212-002 | May 26, 1995 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for ZINECARD
See the table below for patents covering ZINECARD around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Sweden | 400286 | SETT ATT FRAMSTELLA BIS-3,5-DIOXOPIPERAZINER | ⤷ Try a Trial |
Israel | 38342 | BIS(3,5-DIXOPIPERAZIN-1-YL)ALKANE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | ⤷ Try a Trial |
Netherlands | 6902744 | ⤷ Try a Trial | |
France | 2154389 | ⤷ Try a Trial | |
United Kingdom | 1374979 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |